The WACC of Procter & Gamble Health Ltd (PGHL.NS) is 16.3%.
| Range | Selected | |
| Cost of equity | 14.90% - 17.60% | 16.25% |
| Tax rate | 25.60% - 26.70% | 26.15% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 14.9% - 17.6% | 16.3% |
| Category | Low | High |
| Long-term bond rate | 6.9% | 7.4% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 0.97 | 1.05 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 14.90% | 17.60% |
| Tax rate | 25.60% | 26.70% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 14.9% | 17.6% |
| Selected WACC | 16.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PGHL.NS:
cost_of_equity (16.25%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.97) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.